rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Eliav Barr

Director

Company insider

Files Form 4 as: Director, Veracyte.

In numbers

Trades disclosed
6
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
9 Aug 2022
Last trade
11 Jun 2026
Last filed
15 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VCYT VeracyteDirector · Diagnostics & Labs · last 11 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 15 Jun 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—5,272 at $0.00filing
11 Jun 2026filed 15 Jun 2026VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—5,272 at $0.00filing
18 Jun 2025filed 23 Jun 2025VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—9,321 at $0.00filing
13 Jun 2024filed 17 Jun 2024VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—11,473 at $0.00filing
9 Jun 2023filed 13 Jun 2023VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—9,674 at $0.00filing
9 Aug 2022filed 11 Aug 2022VCYT VeracyteDiagnostics & LabsSEC FORM 4 Code A—20,721 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John LeiteGlobal Chief Commercial Off · Global Chief Commercial Off at Veracyte, filing Form 4 there in the last year
Jens HolsteinDirector · Director at Veracyte, filing Form 4 there in the last year
Marc StapleyChief Executive Officer · Chief Executive Officer at Veracyte, filing Form 4 there in the last year
Jonathan WygantVP, Chief Accounting Officer · VP, Chief Accounting Officer at Veracyte, filing Form 4 there in the last year
Phillip G. FebboChief Scientific & Med Officer · Chief Scientific & Med Officer at Veracyte, filing Form 4 there in the last year